Delivery Order SPE2DB25D3003-SPE2DB25FPXAX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $3,274.38. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a continuation of the company's pharmaceutical supply relationship with DLA. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,891.24 on August 6, 2025, for the supply of Januvia 50 mg tablets (90-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through open competition. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,365.84 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Januvia 50 mg tablets (90-count). This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing with a completion date of September 29, 2025. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) on August 14, 2025, with completion targeted for August 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,819.10 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed price delivery order, which is set to conclude by August 27, 2025, will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $1,105.16 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Januvia 100 mg tablets in a 90-count package. This firm fixed-price contract, which is set to be completed by July 31, 2025, represents a single delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $8,972.46 under a firm fixed-price contract structure. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,328.79 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and carries an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXAXDelivery Order
The Defense Logistics Agency awarded a $1,819.10 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Januvia 50 mg tablets (90-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement needs across the Defense Health System. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The award reflects the company's continued role as a primary vendor for diabetes medications and other critical pharmaceuticals supporting federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/27/25 |